Shenzhen

Regional News • Asia • China
Shenzhen becomes first city in China to introduce mandatory paid leave time for workers
Shenzhen becomes first city in China to introduce mandatory paid leave time for workers
Credit: unsplash.com / Robert Bye

Shenzhen, the Chinese technology hub in the south of the country, will be the first city in China to introduce mandatory paid leave time so that employees "with a heavy mental and physical workload can avoid excessive burnout," following the announcement by Shenzhen's work committee.

Health
Chinese officials say chicken wings imported from Brazil tested positive for Covid-19
Chinese officials say chicken wings imported from Brazil tested positive for Covid-19
Credit: unsplash.com / Erik Mclean

A sample of frozen chicken wings imported from Brazil has tested positive for the novel coronavirus in the southern Chinese city of Shenzhen, authorities said Thursday, the latest in a series of reports of contaminated imported food products.

The coronavirus was detected Wednesday on a surface sample taken from a batch of chicken wings during screening of imported frozen food in Longgang district of Shenzhen, the municipal government said in a statement. Officials did not name the brand.

Regional News • Asia • China
Shenzhen announces plans to ban sale and consumption of cat and dog meat

The new law will put into place starting on May 1st. Shenzhen will be the first city in the country to enact such ban and does so after the coronavirus pandemic was linked to the consumption of wildlife animals by scientists. The cities government sai, according to Reuters, that "Dogs and cats as pets have established a much closer relationship with humans than all other animals" and that consumption ban is a common practice in developed countries.

Health
Influenza drug from Japan effective against Covid-19 according to Chinese authorities

A flu drug named favipiravir, developed by a subsidiary of the Japanese company Fujifilm, appears to be effective as a treatment for the coronavirus. According to Zhang Xinmin, an official from the Chinese science and technology ministry, “It has a high degree of safety and is clearly effective in treatment". The drug has been tested in clinical trials ni Wuhan and Shenzhen. In total 340 patients have been treated with it and on average been tested negative for the virus only four days after being tested positive. In addition, the lung condition of 91% of the patients had improved. This is 29% higher than for patients without the flu drug.